L1CAM and endometrial cancer: In a cohort of 1044 patients with molecularly classified endometrial cancer [67], L1CAM expression (tissue microarrays, clone 14.10, dilution 1:300—according to the previous study by the authors [47], cutoff 10%) was found in almost 15% of the cases, and it was a prognostic factor only in the non-specific molecular subgroup.